Isolator-based Grade A/ISO 5 architectures minimize operator interventions, enabling robust contamination control and compliance with EU GMP Annex 1, FDA guidance, PIC/S, and ISO 14644. Lyophilization ...

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing ...

The number of biologics and complex drug products entering clinical trials and the market is rising, and many of the active ...

Ottawa, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The CDMO aseptic filling solutions market is experiencing robust growth and is expected to continue booming throughout the prospective period, propelled by ...

Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations.

In drug manufacturing, aseptic filling is the crucial final step in advancing biologics candidates into the clinic. Whether drug manufacturers outsource the process to a CDMO or bring the filling ...

A holistic approach to validation and quality assurance is essential. Biologic drugs are highly valuable in treating diseases, and assurance of sterility and proper final product quality is essential.

Promising daily monitoring of plant workers' aseptic procedures was not enough to satisfy the FDA that Bristol-Myers Squibb has the persistent problem resolved. "Please provide more information on the ...

DUBLIN--(BUSINESS WIRE)--The "Aseptic Filling Machine Market (2nd Edition): Industry Trends and Global Forecasts to 2035 - Type of Compatible Primary Container, Scale of Operation, System Throughput, ...

Aseptic B/F/S technology integrates blow molding, sterile filling and hermetic sealing in one continuous operation to produce aseptically manufactured pharmaceutical liquid products. Unique to aseptic ...